Long-Term Survival in Patients With Para-Aortic Lymph Node Metastasis With Systematic Retroperitoneal Lymphadenectomy Followed by Adjuvant Chemotherapy in Endometrial Carcinoma
Authors:
- Masamichi HiuraMHMasamichi Hiura
- Takayoshi NogawaTNTakayoshi Nogawa
- Takashi MatsumotoTMTakashi Matsumoto
- Takashi YokoyamaTYTakashi Yokoyama
- Yuko ShiroyamaYSYuko Shiroyama
- Junko WroblewskiJWJunko Wroblewski
- 1 July 2010
- journal article
- research article
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 20 (6) , 1000-1005
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Phase III Trial of Doxorubicin With or Without Cisplatin in Advanced Endometrial Carcinoma: A Gynecologic Oncology Group StudyJournal of Clinical Oncology, 2004
- Analysis of FIGO Stage IIIc Endometrial Cancer PatientsGynecologic Oncology, 2001
- Treatment of node-positive endometrial cancer with complete node dissection, chemotherapy and radiation therapyBritish Journal of Cancer, 1997
- A randomized comparison of doxorubicin alone versus doxorubicin plus cyclophosphamide in the management of advanced or recurrent endometrial carcinoma: A Gynecologic Oncology Group study.Journal of Clinical Oncology, 1994
- Treatment of advanced and recurrent endometrial cancer with cisplatin, doxorubicin, and cyclophosphamideGynecologic Oncology, 1991
- Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A gynecologic oncology group studyGynecologic Oncology, 1991
- Prospective treatment of advanced or recurrent endometrial carcinoma with cisplatin, doxorubicin, and cyclophosphamideGynecologic Oncology, 1990
- AnnouncementsGynecologic Oncology, 1989
- Phase II trial of clsplatin as first-line chemotherapy in patients with advanced or recurrent endometrial carcinoma: A gynecologic oncology group studyGynecologic Oncology, 1989
- Randomized phase II studies of cisplatin and a combination of cyclophosphamide-doxorubicin-cisplatin (CAP) in patients with progestin-refractory advanced endometrial carcinomaGynecologic Oncology, 1987